885066-67-1 (PGD2-IN-1,Pgd2-IN-1)

化合物PGD2-INHIBITOR;

PGD2-IN-1;NULL;PGD2-inhibitor;MDK66671;JXZ83H2X06;2-(3-(6-((2,4-dichlorophenethyl)amino)-2-methoxypyrimidin-4-yl)phenyl)-2-methylpropanoic acid;Benzeneacetic acid,3-[6-[[2-(2,4-dichlorophenyl)ethyl]amino]-2-methoxy-4-pyrimidinyl]-a,a-dimethyl-;prostaglandin D2PGD2) inhibitor;BCP20749;BDBM50417747;N16819;A903614;2-(3-(6-((2-(2,4-Dichlorophenyl)ethyl)am;PGD2-IN-1?, >98%;PGD2-inhibitor, >98%;prostaglandin D2(PGD2) inhibitor;PGD2 inhibitor 1;Benzeneacetic acid, 3-[6-[[2-(2,4-dichlorophenyl)ethyl]amino]-2-methoxy-4-pyrimidinyl]-α,α-dimethyl-;3-[6-[[2-(2,4-Dichlorophenyl)ethyl]amino]-2-methoxy-4-pyrimidinyl]-α,α-dimethylbenzeneacetic acid (ACI);2-[3-[6-[[2-(2,4-Dichlorophenyl)ethyl]amino]-2-methoxypyrimidin-4-yl]phenyl]-2-methylpropionic acid;Benzeneacetic acid, 3-(6-((2-(2,4-dichlorophenyl)ethyl)amino)-2-methoxy-4-pyrimidinyl)-alpha,alpha-dimethyl-;885066-67-1;CS-6338;UNII-JXZ83H2X06;2-(3-(6-((2-(2,4-Dichlorophenyl)ethyl)amino)-2-methoxypyrimidin-4-yl)phenyl)-2-methylpropionic acid;PGD2 inhibitor;DA-57121;2-[3-[6-[2-(2,4-dichlorophenyl)ethylamino]-2-methoxypyrimidin-4-yl]phenyl]-2-methylpropanoic acid;GLXC-10510;MDK-66671;BENZENEACETIC ACID, 3-(6-((2-(2,4-DICHLOROPHENYL)ETHYL)AMINO)-2-METHOXY-4-PYRIMIDINYL)-.ALPHA.,.ALPHA.-DIMETHYL-;HY-101430;2-(3-{6-[2-(2,4-dichloro-phenyl)-ethylamino]-2-methoxy-pyrimidin-4-yl}-phenyl)-2-methylpropionic acid;CHEMBL1644245;SCHEMBL2563601;FJKKCRCBBAXLQZ-UHFFFAOYSA-N;2-[3-(6-{[2-(2,4-dichlorophenyl)ethyl]amino}-2-methoxypyrimidin-4-yl)phenyl]-2-methylpropanoic acid;MS-28432;PGD2-IN-1;MDK66671; MDK-66671 MDK 66671;2-(3-{6-[2-(2,4-dichloro-phenyl)-ethylamino]-2-methoxy-pyrimidin-4-yl}-phenyl)-2-methyl-propionic acid;AKOS032960433;

MFCD30721575

FJKKCRCBBAXLQZ-UHFFFAOYSA-N

1S/C23H23Cl2N3O3/c1-23(2,21(29)30)16-6-4-5-15(11-16)19-13-20(28-22(27-19)31-3)26-10-9-14-7-8-17(24)12-18(14)25/h4-8,11-13H,9-10H2,1-3H3,(H,29,30)(H,26,27,28)

O=C(C(C)(C)C1C=C(C2C=C(NCCC3C(Cl)=CC(Cl)=CC=3)N=C(OC)N=2)C=CC=1)O